Open access

696 Long-term survival of patients with non-small cell lung cancer (NSCLC) stratified by a proteomic test: a sub-analysis
Hefez Halawani, Baochong Chang, Kimberly Le

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A788; DOI: 10.1136/jitc-2023-SITC2023.0696
697 Pulsed Electric Fields induces a stepwise activation of host anti-tumor immunity in patients with early-stage non-small cell lung cancer (NSCLC)
Marcelo Jimenez, José Fernández García-Hierro, Javier Flandes Aldeyturriaga, Erik HFM van der Heijden, Calvin Ng, Rainbow Lau, Borja Recalde, Carlos Prieto, Alberto Orfao, Roel Verhoeven, Alicia Moreno-Gonzalez, Beryl Hatton, Ebtesam Nafie, Gloria Mas Martin, William Krimsky

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A789-A791; DOI: 10.1136/jitc-2023-SITC2023.0697
698 Safety and tolerability of magrolimab in combination with taxanes in patients with solid tumors
Oscar Juan-Videl, Joanne Chiu, Ulka N Vaishampayan, Rohit Joshi, Muhammad Furqan, Natalie Rainey, Bruno Fang, William Lawler, Brian Vicuna, Wen Xu, Jiang Shao, Fadi Shihadeh, Ann Chen, Aoife Sills, Estibaliz Lopez, Sylvia Adams

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A792-A793; DOI: 10.1136/jitc-2023-SITC2023.0698
699 Phase 2 trial of brentuximab vedotin (BV) with pembrolizumab (pembro) in patients with metastatic non-small cell lung cancer or metastatic cutaneous melanoma after progression on anti-PD-1 therapy
Sylvia Lee, Robert M Jotte, Amanda Gillespie-Twardy, Inderjit Mehmi, Sunandana Chandra, Yousef Zakharia, Omid Hamid, Graham Watson, Patrick Ward, Marya Chaney, Hailing Lu, Jason D Berndt, Kapil Rathi, Scott Knowles, Brian P O’Connor, Charles Cowey

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A794; DOI: 10.1136/jitc-2023-SITC2023.0699
700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study
Hirva Mamdani, Seongho Kim, Jie Chi, Kristen Pizana, Qura Abid, Shadia I Jalal

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A795; DOI: 10.1136/jitc-2023-SITC2023.0700
701 Aiming high in HI-AIM; a clinical testing of exercise in cancer
Gitte Olofsson, Thy V Luu, Katharina Leuchte, Line Fleicher Nielsen, Agnete WP Jensen, Per thor Straten

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A796; DOI: 10.1136/jitc-2023-SITC2023.0701
702 Phase 1 study of DLL3-directed chimeric antigen receptor T-cells in subjects with extensive stage small cell lung cancer
Jacob Sands, Adam Schoenfeld, Paul Schwarzenberger, Christopher delCorral, Dong Geng, Zhong Yun, Chaun Wang, Gianni Amato, Sahista Vahora, Lida Pacaud, Zhonglin Hao, Alberto Chiappori

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A797; DOI: 10.1136/jitc-2023-SITC2023.0702
703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition
James Dollar, Christina Decatur, Anthony Cruz, Michael Durante, Jani Huuhtanen, Satu Mustjoki, Zelia Correa, J William Harbour, Jose Lutzky

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A798; DOI: 10.1136/jitc-2023-SITC2023.0703
704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer
Juraj Adamik, Adam Grant, Damian Trujillo, Rakesh Kumar Goyal, William Ho, Michael Chisamore, Shoji Ikeda, Marvin Au, Denise Nagata, Eugene Lurie, Qingfeng Zhu, Robert Anders, Dirk G Brockstedt, Mohsen Sabouri Ghomi, Paul D Kassner

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A799; DOI: 10.1136/jitc-2023-SITC2023.0704
705 Biodistribution and shedding analysis following RP1 oncolytic immunotherapy dosing in patients from the IGNYTE clinical trial
Praveen K Bommareddy, Alina Monteagudo, Mohammed Milhem, Joseph J Sacco, Tawnya Lynn Bowles, Katy K Tsai, Gino K In, Eva Muñoz-Couselo, Ari M VanderWalde, Jason Alan Chesney, Judith Michels, Adel Samson, Georgia M Beasley, Trisha M Wise-Draper, Dirk Schadendorf, Fade Mahmoud, Michael K Wong, Walter Hong, Jeannie W Hou, Aaron Clack, Robert S Coffin, Mark R Middleton, Bartosz Chmielowski

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A800; DOI: 10.1136/jitc-2023-SITC2023.0705

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages